1 2 3 4 5 Next
Illumina Launches New Software Support Program for Downstream Analysis of Microarray Data
SAN DIEGO, Calif.----Illumina, Inc. today announced the launch of Illumina Connect, a bioinformatics software partnership program established to advance data integration and analysis. (Tue, 01 May 2007 10:00:00 GMT)
Industry Veteran Dindyal Ramkissoon Joins CombiMatrix Molecular Diagnostics as VP of Sales and Marketing
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that industry veteran, Dindyal Ramkissoon has been appointed Vice President of Sales and Marketing of its CombiMatrix group's subsidiary, Combimatrix Molecular Diagnostics, Inc. . (Tue, 01 May 2007 10:00:00 GMT)
Animal BiP levels determine amount of recovery sleep needed following prolonged wakefulness
WESTCHESTER, Ill. -- Microarray studies have identified numerous genes that change in response to prolonged wakefulness. Determining which transcriptional changes translate into protein changes that are critical for recovery during sleep loss, however, can be challenging. (Tue, 01 May 2007 10:07:57 GMT)
Comparison of two plankton species' genomes yields surprising results for scientists
Washington, May 1 (ANI): An international team of researchers have for the first time studied the genetic makeup of two species of phytoplankton - tiny plants that play a key role in global photosynthesis and carbon cycling. "Through our research we've been trying to understand Ostreococcus' role in marine ecosystems. Genomics has taught us that you can learn much more when you can ... (Tue, 01 May 2007 10:33:01 GMT)
Matritech Reports First Quarter 2007 Financial Results
NEWTON, Mass.----Matritech , a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the first quarter ended March 31, 2007. (Tue, 01 May 2007 11:00:00 GMT)
CORRECTING and REPLACING Industry Veteran Dindyal Ramkissoon Joins CombiMatrix Molecular Diagnostics as VP of Sales and ...
NEWPORT BEACH, Calif.----The ticker for CombiMatrix Group was listed incorrectly. The correct ticker is . (Tue, 01 May 2007 11:02:00 GMT)
Industry Veteran Dindyal Ramkissoon Joins CombiMatrix Molecular Diagnostics as VP of Sales and Marketing
NEWPORT BEACH, Calif., (Tue, 01 May 2007 11:38:19 GMT)
GenomeQuest, Inc. Announces Collaboration with Servier to Improve Specificity of Microarray Probes and qPCR Results
WESTBOROUGH, Mass.----GenomeQuest, Inc. a leader in sequence search for research and IP, today announced a collaboration with Servier, the leading French independent pharmaceutical company, to seamlessly connect results from high-throughput microarray experiments to qPCR platforms from different vendors, including Servier proprietary reagent data sets. (Tue, 01 May 2007 12:00:00 GMT)
GenomeQuest, Inc. Announces GenomeQuest(TM) 4.0 Web Application for Sequence Search Analysts in Biotech Law and Research
WESTBOROUGH, Mass.----Seeking to expand beyond its commanding market position in gene patent and portfolio management information, GenomeQuest, Inc. is reaching out to biotech researchers with GenomeQuest 4.0, a new, web-enabled platform for genetic sequence data search and analysis. (Tue, 01 May 2007 12:00:00 GMT)
GenVec Announces Additional Funding for Malaria Vaccine Program from the PATH Malaria Vaccine Initiative
GAITHERSBURG, Md.----GenVec, Inc. announced today that the Company has amended and extended its existing Collaborative Research, Development and Supply Agreement with the PATH Malaria Vaccine Initiative . (Tue, 01 May 2007 12:00:00 GMT)
Education News & Events
Chris Stenger and Robert Stenger Jr., sons of Robert and Christy Stenger of Salinas and grandson of Clinton and Diane Smith of Gainesville, Texas, and Ron and Alice Stenger of Brookville, Tenn., have been named All-American Scholars. (Tue, 01 May 2007 12:13:35 GMT)
University study examines seasonal behavioral changes
The study, featured in the leading national biology journal Cell, suggests a connection between depression and biological rhythm in humans. (Tue, 01 May 2007 12:18:51 GMT)
QuantRx(R) Biomedical Announces Addition to Scientific Research Leadership
QuantRx® Biomedical Corporation, an emerging leader in the research and development of medical diagnostic platforms and products, today announced that Anthony Burgess-Cassler, Ph.D., has been named senior scientist at the QuantRx Corporate Research Center in Portland, Oregon. (Tue, 01 May 2007 12:32:00 GMT)
CORRECTING and REPLACING Industry Veteran Dindyal Ramkissoon Joins CombiMatrix Molecular Diagnostics as VP of Sales and ...
NEWPORT BEACH, Calif., BUSINESS WIRE -- The ticker for CombiMatrix Group was listed incorrectly. The correct ticker is (NASDAQ: CBMX). (Tue, 01 May 2007 12:38:21 GMT)
BioServe Acquires Genomics Collaborative
BioServe, a leading provider of genomics services, today announced that it has acquired Genomics Collaborative from SeraCare Life Sciences, Inc. Genomics Collaborative is a leader in facilitating biomarker discovery and validation through its Global Repository®, a comprehensive library of 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 140,000 ... (Tue, 01 May 2007 13:00:00 GMT)
Alzheimer's, Parkinson's, type 2 diabetes similar at molecular level
Alzheimer’s disease, Parkinson’s disease, type II diabetes, the human version of mad cow disease and other degenerative diseases are more closely related at the molecular level than many scientists realized, an international team of chemists and molecular biologists reported April 29 in the online version of the journal Nature (print version to follow). (Tue, 01 May 2007 13:22:13 GMT)
Bioinformatics tool updated: Geneious Pro 3
New Zealand-based Biomatters has released Geneious Pro 3.0, an update to the application for scientists designed to search, organize, access, visualize and analyze genomic information. The company says that Geneious Pro 3.0 delivers a 'backbone' application connecting the spectrum of biological science, enabling existing and future software researc... (Tue, 01 May 2007 14:06:54 GMT)
Waters and Northeastern University Open New Laboratory for Protein Research Focused on the World's Deadliest Diseases
Waters Corporation and Northeastern University today opened the doors of the new Waters Mass Spectrometry Laboratory within the renowned Barnett Institute of Chemical and Biological Analysis at the University. (Tue, 01 May 2007 14:10:00 GMT)
Rosetta Genomics Announces First Source for Clinical Validation of its Cancer of Unknown Primary (CUP) Diagnostic Test
REHOVOT, Israel and DETROIT, Michigan, May 1 /PRNewswire-FirstCall/ -- Rosetta Genomics ( Nachrichten ) announced today that it has signed an agreement with the Henry Ford Hospital in Detroit, Michigan, one of the world's leading research centers for brain cancer, to provide the company with samples of metastases found in brain tissue. (Tue, 01 May 2007 14:36:48 GMT)
Pressure BioSciences, Inc. To Unveil New, Lightweight, Compressed Air Driven Barocycler Instrument At BIO 2007
Pressure BioSciences, Inc. today announced that it will unveil a patent-pending, lightweight, compressed air driven pressure cycling instrument (Barocycler NEP2320) at the 2007 BIO International Convention, being held May 6-9 in Boston, Massachusetts (Tue, 01 May 2007 15:02:18 GMT)
SGI Scientific Workflow Solutions With Strategic Software Vendors Demonstrate Accelerated Research Results At Bio-IT ...
BioIT World, booth #405 -- An exciting, yet logical new approach that enables scientific organizations to deploy the best computing platform for each application workload is being showcased by SGI this week in Boston at the BioIT World 2007 Conference and Expo (Tue, 01 May 2007 15:02:38 GMT)
BioServe Acquires Genomics Collaborative From SeraCare Life Sciences
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 01 May 2007 15:14:17 GMT)
Hutchinson Center Establishes New Vaccine and Infectious Disease Institute
Fred Hutchinson Cancer Research Center has established a new Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria and cancer. (Tue, 01 May 2007 17:36:00 GMT)
New technology detects functional genes
The GeoChip created by U.S. scientists is described as a genomics-based tool that can detect functional genes and processes in a microbial community. (Tue, 01 May 2007 17:51:09 GMT)
Rosetta Genomics First Quarter 2007 Financial Results Conference Call
Rosetta Genomics, Ltd. announced that the company will report first quarter 2007 financial results on Tuesday, May 8, 2007, after U.S. financial markets close. Following the announcement, senior management will host a conference call and webcast at 4:30 p.m. (Tue, 01 May 2007 18:00:00 GMT)
Rosetta Genomics to Announce First Quarter 2007 Financial Results and Host Conference Call on Tuesday, May 8, 2007
Rosetta Genomics, Ltd. announced that the company will report first quarter 2007 financial results on Tuesday, May 8, 2007, after U.S. financial markets close. Following the announcement, senior management will host a conference call and webcast at 4:30 p.m. (Tue, 01 May 2007 18:00:00 GMT)
New technology detects functional genes
The GeoChip created by U.S. scientists is described as a genomics-based tool that can detect functional genes and processes in a microbial community.The gene chip technology created by Jizhong Zhou and colleagues at the University of Oklahoma consists of a collection of microscopic DNA spots on a tiny chip, with each spot representing a different gene probe. The GeoChip contains more than 24,000 ... (Tue, 01 May 2007 18:09:56 GMT)
14 RABI-US-SAINI 1428 AH SRINAGAR WEDNESDAY, MAY 02, 2007
Bioinformatics or computational biology refers to an emerging, interdisciplinary subject in which computer technology, including software, hardware and algorithms, are applied to solving problems arising in biology. (Tue, 01 May 2007 18:48:52 GMT)
Rosetta Genomics Announces First Source for Clinical Validation of Its Cancer of Unknown Primary (CUP) Diagnostic Test
REHOVOT, Israel and DETROIT, Michigan, May 1 / (Tue, 01 May 2007 19:03:08 GMT)
Canisius science center ties with M&T
Canisius College will develop five research training groups at its new science center with help from a $500,000 challenge grant from M&T Bank. (Tue, 01 May 2007 19:13:44 GMT)
Aushon BioSystems Appoints Ken Titlebaum Chief Financial Officer and Mike Tognotti VP of Worldwide Sales and Marketing
BURLINGTON, Mass.----Aushon BioSystems, developer of advanced products for microarray-based analysis, announced today the appointments of Ken Titlebaum as Chief Financial Officer and Mike Tognotti as Vice President of Worldwide Sales and Marketing. (Tue, 01 May 2007 19:17:00 GMT)
Invitrogen Announces First Quarter 2007 Results
CARLSBAD, Calif.----Invitrogen Corporation today announced results for its first quarter ended March 31, 2007. Revenue for the first quarter was $309 million, an increase of 10 percent over first quarter 2006 revenue of $280 million, excluding the impact of discontinued operations. (Tue, 01 May 2007 20:35:00 GMT)
Alzheimer’s, Parkinson’s, Type II Diabetes Are Similar At The Molecular Level
Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized. (Tue, 01 May 2007 21:08:27 GMT)
Hutchinson Center Establishes New Vaccine and Infectious Disease Institute
SEATTLE, May 1 /PRNewswire/ -- Fred Hutchinson Cancer Research Center has established a new Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria and cancer. (Tue, 01 May 2007 22:04:27 GMT)
RNA analysis can identify rejection in lung transplant patients
Recent data from the Lung Allograft Rejection Gene expression Observational (LARGO) study provides compelling evidence that profiling gene expression in peripheral blood can detect organ rejection in lung transplant patients. (Wed, 02 May 2007 00:05:18 GMT)
BioWorld International Correspondent
Proteomics research in Denmark has received a substantial boost - in the form of a DKK600 million (US$109 million) grant from the Novo Nordisk Foundation to establish a new center for protein research at the University of Copenhagen. (Wed, 02 May 2007 04:11:45 GMT)
Biosite and Beckman Coulter Amend Definitive Merger Agreement
Biosite Incorporated today announced that it and Beckman Coulter, Inc. have entered into an amendment to their existing merger agreement dated March 24, 2007. (Wed, 02 May 2007 06:15:00 GMT)
Biosite and Beckman Coulter Amend Definitive Merger Agreement
SAN DIEGO, May 2 /PRNewswire-FirstCall/ -- Biosite Incorporated ( Nachrichten ) today announced that it and Beckman Coulter, ( Nachrichten ) Inc. have entered into an amendment to their existing merger agreement dated March 24, 2007. Under the terms of the amendment to the merger agreement, Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer for $90.00 ... (Wed, 02 May 2007 06:24:04 GMT)
Upcoming Xtalks Web Conference Explores Opportunities and Perspectives of Personalized Medicine
In a Xtalks Web Conference on Wednesday, May 30, 2007, 1:00 - 3:00pm EST, Raymond Woosley, MD, PhD, President and CEO, The Critical Path Institute, Mara G. (Wed, 02 May 2007 07:01:00 GMT)
Upcoming Xtalks Web Conference Explores Opportunities and Perspectives of Personalized Medicine
In a Xtalks Web Conference on Wednesday, May 30, 2007, 1:00 - 3:00pm EST, Raymond Woosley, MD, PhD, President and CEO, The Critical Path Institute, Mara G. Aspinall, President, Genzyme Genetics, Wayne Rosenkrans, Business Strategy Director External Scientific Affairs, Co-Chair Personalized Medicine Coalition, AstraZeneca Pharmaceuticals, and Dr. Elaine Weidenhammer, Associate Director, Strategic ... (Wed, 02 May 2007 07:27:11 GMT)
News Tips From The Journal Of Biological Chemistry
Cholesterol Metabolism Without OxygenThis article was featured as a "Paper of the Week" by the Journal of Biological Chemistry's Editors, meaning that it belongs to the top one percent of papers reviewed in significance and overall importance.Researchers report the first details of how cholesterol is metabolized without oxygen. [click link for full article] (Wed, 02 May 2007 09:04:21 GMT)
Acacia Technologies Acquires Patent for Text Auto-Completion Technology
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired a patent relating to text auto-completion technology. (Wed, 02 May 2007 11:23:22 GMT)
Nanogen to Host First Quarter Conference Call and Webcast on May 9, 2007
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, will host a conference call on Wednesday, May 9, 2007, at 5:00 p.m. Eastern to discuss 2007 first quarter financial results. (Wed, 02 May 2007 12:00:00 GMT)
Affymetrix to Webcast Presentation at Baird Growth Stock Conference
SANTA CLARA, Calif.----Affymetrix, Inc. today announced it will webcast its presentation at the Baird Growth Stock Conference in Chicago. Doug Farrell, Vice President of Investor Relations, will provide a company overview at 11:50 a.m. (Wed, 02 May 2007 13:00:00 GMT)
AlgoNomics Selects CTCLS as Japanese Representative for Its Immunogenicity Screening Services
GHENT, Belgium & TOKYO----AlgoNomics, a global provider of immunogenicity screening solutions, and CTC Laboratory Systems Corporation , a leading supplier of software, services and consultancy to the Japanese pharmaceutical and biotech industry, today announced to have entered into an agreement for AlgoNomics' Epibase® screening technology. (Wed, 02 May 2007 13:00:00 GMT)
Ingenuity Systems Announces Molecular Toxicology Solution
REDWOOD CITY, Calif., (Wed, 02 May 2007 13:00:11 GMT)
SIM2 Gene Focus of Cancer Research Agreement with FAU and Torrey Pines Inst. for Molecular Studies
A research team at FAU has identified a cancer specific gene called SIM2. This gene is found on chromosome 21 and is normally associated with Down's syndrome. Researchers identified the SIM2 gene using an approach called bioinformatics, which uses the power of computers to understand biology and medicine. (Wed, 02 May 2007 13:24:49 GMT)
Matritech, Inc. (Amex: MZT) Q1/07 Review issued by Scimitar Equity Research, Inc.
Scimitar Equity Research, Inc. issues a review on Matritech, Inc. entitled "Revenue and Net Loss Increased, Guidance is Reaffirmed and Debt Increases the Need to Examine Future Options." (Wed, 02 May 2007 14:43:00 GMT)
Study: Some diseases molecularly related
A U.S.-led international study suggests Alzheimer's, Parkinson's and other degenerative diseases are more molecularly linked than has been thought. Harmful rope-like structures known as amyloid fibrils, which are linked protein molecules that form in t (Wed, 02 May 2007 15:51:14 GMT)
AlgoNomics Selects CTCLS As Japanese Representative for Its Immunogenicity Screening Services
AlgoNomics, a global provider of immunogenicity (Wed, 02 May 2007 16:04:21 GMT)
Study: Some diseases molecularly related
LOS ANGELES, May 2: A U.S.-led international study suggests Alzheimer's, Parkinson's and other degenerative diseases are more molecularly linked than has been thought. (Wed, 02 May 2007 16:59:23 GMT)
Adam Siepel receives Microsoft fellowship for computational genomics
Adam Siepel, Cornell assistant professor of biological statistics and computational biology, has been named one of five awardees for Microsoft Research's 2007 New Faculty Fellowship Program. (Wed, 02 May 2007 17:42:42 GMT)
Torrey Pines to help FAU with cancer research
Florida Atlantic University said its faculty and students will use compounds from the Torrey Pines Institute for Molecular Studies to work to identify anti-cancer drugs and therapies. (Wed, 02 May 2007 17:46:51 GMT)
New lab-on-a-chip device to speed proteomics research
In recent years, the science of biology has been dominated by genomics - the study of genes and their functions. The genomics era is now making way for the era of proteomics - the study of the proteins that genes encode. Future proteomics research should see a substantial acceleration with the development of a new device that provides the first monolithic interface between mass spectrometry and ... (Wed, 02 May 2007 18:03:58 GMT)
Lumera Extends Collaborative Research Agreement with the Institute for Systems Biology
BOTHELL, Wash.----Lumera Corporation , a leader in the emerging field of nanotechnology, announced today that it has extended its collaboration agreement with the Institute for Systems Biology . (Wed, 02 May 2007 18:21:00 GMT)
Niagara U. campaign seeks $80M
Niagara University announced Wednesday a major reorientation of its Lewiston campus, launching a five-year $80 million fundraising campaign to pay for the project. (Wed, 02 May 2007 18:59:09 GMT)
Lab-on-a-chip Device To Speed Proteomics Research
Future proteomics research should see a substantial acceleration with the development of a new device that provides the first monolithic interface between mass spectrometry and silicon/silica-based microfluidic "lab-on-a-chip" technologies. This new device is called a multinozzle nanoelectrospray emitter array. (Wed, 02 May 2007 20:06:34 GMT)
Luminex Corporation Reports First Quarter 2007 Results ------------------------- Core Business Achieves Record Revenue ...
Luminex Corporation today announced financial results for the first quarter ended March 31, 2007. (Wed, 02 May 2007 20:40:00 GMT)
Case Comprehensive Cancer Center Unveils State-of-the-Art Technology For Solid Tumor Research
A new suite of core facility services is now available at the Case Comprehensive Cancer Center. The Center, a consortium of Case Western Reserve University School of Medicine, University Hospitals Case Medical Center and the Cleveland Clinic, is a comprehensive cancer center designated by the National Cancer Center Institute. [click link for full article] (Wed, 02 May 2007 22:04:12 GMT)
Biosite Incorporated Reports New Option Grants Under NASDAQ Marketplace Rule 4350
Biosite® Incorporated , today announced that, in accordance with NASDAQ Marketplace Rule 4350, 18 non-officer employees were granted inducement stock options covering an aggregate of 17,200 shares of common stock. (Thu, 03 May 2007 00:01:00 GMT)
Luminex Corporation Reports First Quarter 2007 Results ------------------------- Core Business Achieves Record Revenue ...
Luminex Corporation today announced financial results for the first quarter ended March 31, 2007. (Thu, 03 May 2007 00:39:40 GMT)
New virus test technology experimented
Hangzhou (China), May 3 (Xinhua) A new diagnostic technology to detect epidemic diseases has entered the phase of clinical experiments, claimed a Chinese scientist. (Thu, 03 May 2007 03:40:53 GMT)
CLC bio joins $2.5 mn research project on RNA-based diseases
CLC bio, the IT University of Copenhagen, and the Department of Molecular Biology at the interdisciplinary nano science centre (iNANO) of University of Aarhus announced that the Danish Council for Strategic Research has approved to fund the ambitious and ground-breaking research project PC Mini Grids for Prediction of Viral RNA Structure and Evolution. (Thu, 03 May 2007 05:19:05 GMT)
New virus test technology experimented
A new virus test technology featuring DNA test has entered the phase of clinical experiment, said a scientist in east China. (Thu, 03 May 2007 05:51:48 GMT)
Agilent Technologies Awards Microarray Prize To Dutch Scientist For Research On Tumor Suppressor Genes
Agilent Technologies Inc. recently announced that Klaas Kok, Ph.D., of the Department of Genetics, University Medical Center Groningen in the Netherlands, has won 50 free microarrays in the Agilent Technologies Microarray Contest on the basis of his innovative research (Thu, 03 May 2007 06:58:01 GMT)
BioServe acquires Genomics Collaborative
BioServe, a leader in genomics services, announced it had acquired Genomics Collaborative from SeraCare Life Sciences Inc. (Thu, 03 May 2007 07:15:04 GMT)
CLC bio joins $2.5M research project on HIV, bird flu, and other RNA-based diseases
CLC bio, the IT University of Copenhagen, and the Department of Molecular Biology at the interdisciplinary nano science centre (iNANO) of University of Aarhus are proud to announce that the Danish Council for Strategic Research has approved to fund the ambitious and ground-breaking research project PC Mini Grids for Prediction of Viral RNA Structure and Evolution. [Wired by: ... (Thu, 03 May 2007 07:32:07 GMT)
Fred Hutchinson Cancer Research Center establishes new vaccine and disease institute
Fred Hutchinson Cancer Research Center has established a new Vaccine and Infectious Disease Institute to develop and implement prevention strategies for globally important infectious diseases, including HIV, malaria and cancer. (Thu, 03 May 2007 09:21:23 GMT)
AutoGenomics Receives FDA Clearance for Its Infiniti Analyzer
AutoGenomics Inc., a leader in developing automated molecular testing solutions, announced today that it has obtained clearance from the FDA to market its INFINITI Analyzer as stand alone instrumentation for multiplexed assays. (Thu, 03 May 2007 10:00:00 GMT)
Acacia Technologies Licenses Pop-up Advertisement Technology to Discovery Communications Corporation
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that InternetAd Systems, LLC, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has entered into a license with Discovery Communications Corp., covering a portfolio of patents that apply to Pop-Up Advertising. (Thu, 03 May 2007 10:01:00 GMT)
The X PRIZE Foundation Announces New Competitor for Pioneering Genome Sequencing Prize
SANTA MONICA, Calif.----Reveo, Inc. has joined the competition to win the largest medical prize in history, the $10 million Archon X PRIZE for Genomics. The prize will be awarded to the first team that can develop a tool to sequence 100 human genomes in 10 days, costing no more than $10,000 per genome with 99.999% accuracy. (Thu, 03 May 2007 11:00:00 GMT)
Acacia Technologies Acquires Rights to Patent for Parallel Processing with Shared Memory
NEWPORT BEACH, Calif., BUSINESS WIRE -- Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that Acacia Patent Acquisition Corporation, a wholly owned subsidiary that is part of the Acacia Technologies group, a leader in technology licensing, has acquired rights to a patent relating to parallel processors with shared memory. (Thu, 03 May 2007 11:23:20 GMT)
Acacia Technologies Licenses Pop-up Advertisement Technology to Discovery Communications Corporation
NEWPORT BEACH, Calif., (Thu, 03 May 2007 11:23:30 GMT)
Affymetrix Introduces Targeted Genotyping Bovine 25K SNP Service to Improve Quality of Dairy and Beef Cattle
SANTA CLARA, Calif.----Affymetrix Inc. announced today the launch of its Targeted Genotyping Bovine 25K SNP Service, which includes a new assay panel designed to help agricultural researchers improve the health of cattle and the nutritional value of beef and dairy products. (Thu, 03 May 2007 12:00:00 GMT)
NU sets $80 million goal
LEWISTON — Niagara University embarked on the most significant fundraising campaign in its history Wednesday, pledging to raise $80 million over the next five years to build new facilities, enhance the campus and support academics. (Thu, 03 May 2007 12:08:15 GMT)
X PRIZE Foundation Adds Genomics Competitor
The Santa Monica-based X PRIZE Foundation announced this morning that it has added a new company to its list of competitors for the $10M Archon X Prize for Genomics. The foundation said that Reveo, Inc., has joined VisiGen Biotechnologies, Inc.... (more) (Thu, 03 May 2007 13:47:35 GMT)
Cerebral malaria: Approaching a diagnostic test
Scientists at CNRS and the Pasteur Institute, collaborating with physicians in Gabon, have just undertaken a study on cerebral malaria in children living in an endemic region. (Thu, 03 May 2007 14:07:57 GMT)
Reveo Joins Genomics X Prize Race; Aims to Sequence Genome, Proteome, and Epigenome 'for Pennies in Minutes'
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 03 May 2007 14:29:34 GMT)
Danish University Wins $18.2M Novo Nordisk Grant to Build Proteomics Center
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 03 May 2007 14:29:36 GMT)
Rosetta Genomics Ltd. Announces the Appointment of J. Michael French to President of its U.S Subsidiary, Rosetta ...
Rosetta Genomics, Ltd. announced today the appointment of J. Michael French as the new President of its U.S. subsidiary, Rosetta Genomics, Inc. (Thu, 03 May 2007 14:34:00 GMT)
Lab-On-A-Chip Device From Berkeley Lab To Speed Proteomics Research
In recent years, the science of biology has been dominated by genomics - the study of genes and their functions. The genomics era is now making way for the era of proteomics - the study of the proteins that genes encode (Thu, 03 May 2007 15:32:08 GMT)
2007 BIO International Convention Exhibitor Profiles, A Through D
BOSTON----2007 BIO International Convention, the Global Event for Biotechnology, takes place May 06 - 09, 2007 at the Boston Convention & Exhibition Center. For in-depth information about the event, visit http://www.bio2007.org/Media/r . (Thu, 03 May 2007 16:29:00 GMT)
2007 BIO International Convention Exhibitor Profiles Continued, M through Z
BOSTON----2007 BIO International Convention, the Global Event for Biotechnology, takes place May 06 - 09, 2007 at the Boston Convention & Exhibition Center. For in-depth information about the event, visit http://www.bio2007.org/Media/r . (Thu, 03 May 2007 16:35:00 GMT)
Story ideas from the Journal of Lipid Research
Researchers have found that a diet rich in fish, seafood, and grains – also called polyunsaturated fats – is better at preventing heart disease than a diet containing olive oil, nuts, and avocados – called monounsaturated fats. (Thu, 03 May 2007 16:55:12 GMT)
New Research Uncovers Fresh Evidence Linking Genes to Heart Disease
Researchers at the University of Ottawa Heart Institute have identified a piece of the DNA sequence that boosts a person's susceptibility to heart disease by up to 40 per cent regardless of other established risks such as cholesterol, blood pressure and diabetes. (Thu, 03 May 2007 18:59:00 GMT)
Fish, Seafood Better Than Olive Oil, Nuts Against Heart Disease
Researchers have found that a diet rich in fish, seafood, and grains -- also called polyunsaturated fats -- is better at preventing heart disease than a diet containing olive oil, nuts, and avocados -- called monounsaturated fats. Although both types of fats are healthy, people should probably include more of the first than the second in their diet to keep a healthy heart, the scientists say. ... (Thu, 03 May 2007 19:04:32 GMT)
Heart Disease Linked To Too Much Cholesterol In Cell Organelle
Scientists have shown that a build-up of cholesterol in cell organelles called lysosomes is related to a higher incidence of heart disease. Atherosclerosis, a heart disease in which fat accumulates in arteries and blocks blood flow, is the leading cause of death in the Western World. [click link for full article] (Thu, 03 May 2007 19:04:52 GMT)
New Link Between Down Syndrome And Alzheimer's Disease
Scientists have shown that a protein involved in cholesterol metabolism may cause the accelerated onset of Alzheimer's Disease in individuals affected with Down Syndrome. People with Down Syndrome -- a genetic disorder due to the presence of an extra chromosome 21 -- develop Alzheimer's disease (AD) earlier (mid- to late 30s) than the general population (mid- to late 70s). [click link for full ... (Thu, 03 May 2007 19:05:06 GMT)
How Lipids Anchor Proteins On A Cell Membrane
Peter Orlean and Anant K. Menon describe how a lipid that helps proteins attach to cell membranes is made. The protein, called glycosylphosphatidylinositol (GPI), is important because people with defective GPI can develop seizures, have heart attacks, and acquire a hemolytic condition in which red blood cells are destroyed. [click link for full article] (Thu, 03 May 2007 19:05:13 GMT)
Study to Probe How Healthy Younger Adults Make Use of Genetic Tests
The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions. (Thu, 03 May 2007 19:05:35 GMT)
$4.4 Million NIH Grant Renews Echinacea and St John's Wort Research
The Iowa Center for Research on Botanical Dietary Supplements at Iowa State received a $4.4 million renewal grant from NIH. Since 2002, researchers have gained insight into the antiviral, anti-inflammatory and immune-boosting mechanisms of specific species of Echinacea, and the antiviral and anti-inflammatory activity of different populations of St. John's wort. (Thu, 03 May 2007 20:25:27 GMT)
Lumera Extends Collaborative Research Agreement With The Institute For Systems Biology
Lumera Corporation, a leader in the emerging field of nanotechnology, announced that it has extended its collaboration agreement with the Institute for Systems Biology (ISB). The goal of the collaboration is to use Lumera's ProteomicProcessorT to identify biomarkers associated with drug toxicity and cancer (Thu, 03 May 2007 21:02:43 GMT)
New Research Uncovers Fresh Evidence Linking Genes To Heart Disease
Researchers at the University of Ottawa Heart Institute (UOHI) have identified a piece of the DNA sequence that boosts a person's susceptibility to heart disease by up to 40 per cent regardless of other established risks such as cholesterol, blood pressure and diabetes. [click link for full article] (Fri, 04 May 2007 07:07:02 GMT)
Interview With Dr. Von Eschenbach on Dendreon's Provenge Approval
T.W Galt submits: On April 15, 2007, an interview featuring Dr. Von Eschenbach, the Director of the FDA, was aired on CSPAN. Dr. Von Eschenbach is the man who ultimately approves Dendreon's application for Provenge. (Fri, 04 May 2007 08:44:09 GMT)
How Healthy Younger Adults Make Use of Genetic Tests
Multiplex Initiative Offers Genetic Testing to Participants in Metropolitan Detroit (Fri, 04 May 2007 09:57:42 GMT)
Acacia Technologies Licenses Credit Card Fraud Protection Technology to Skechers, U.S.A.
NEWPORT BEACH, Calif.----Acacia Research Corporation announced today that Financial Systems Innovation LLC, a wholly owned subsidiary of the Acacia Technologies group, a leader in technology licensing, has entered into non-exclusive licenses covering a patent that applies to credit card fraud protection technology with Skechers, U.S.A., Inc. (Fri, 04 May 2007 10:00:00 GMT)
Tissue Proteomic Alliance Announced by Expression Pathology and ORIDIS Biomed
Expression Pathology Inc. and ORIDIS Biomed GmbH announced today a strategic alliance to offer tissue microproteomic capabilities for protein biomarker discovery and validation. The relationship combines Expression Pathology's proprietary Liquid Tissue® and DIRECTOR technologies, which enable mass spectrometry-based discovery and measurement of protein biomarkers in archival tissue, with ORIDIS ... (Fri, 04 May 2007 11:01:00 GMT)
Bristol-Myers Squibb Joins Oslo Cancer Cluster
Oslo Cancer Cluster today announced at BIO2007 that Bristol-Myers Squibb Norway is the latest leading pharmaceutical company to join this major private-public initiative in one of Europe's rising biopharma regions. (Fri, 04 May 2007 11:18:58 GMT)
Acacia Technologies Licenses Credit Card Fraud Protection Technology to Skechers, U.S.A.
NEWPORT BEACH, Calif., (Fri, 04 May 2007 11:23:35 GMT)
New Report Examines Strategies for Exploiting the Power of Genomics to Inform Studies in Immunology
DUBLIN, Ireland----Research and Markets has announced the addition of Decoding the Genomic Control of Immune Reactions: Novartis Foundation Symposium, No 281 to their offering. (Fri, 04 May 2007 13:00:00 GMT)
Biosite Determines that Offer from Inverness Constitutes a 'Superior Proposal'
Beckman Coulter Has Right to Match Offer Under Merger Agreement SAN DIEGO, April 25 / -- Biosite Incorporated (NASDAQ:BSTE) today announced that it has received a binding offer from Inverness Medical Innovations, Inc. (AMEX:IMA) to enter into a merger transaction pursuant to which Inverness would acquire 100% of the outstanding shares of common stock of Biosite, other than Biosite shares already ... (Fri, 04 May 2007 13:04:15 GMT)
Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer
SAN DIEGO, April 24 / -- Biosite Incorporated (NASDAQ:BSTE) today announced that Beckman Coulter, Inc. (NYSE:BEC) has obtained clearance from the German Federal Cartel Office (the Bundeskartellamt) in connection with its proposed acquisition of Biosite pursuant to the tender offer described below. The tender offer is conditioned upon at least a majority of the outstanding Biosite shares, ... (Fri, 04 May 2007 13:04:35 GMT)
Study to probe how healthy younger adults make use of genetic tests
BETHESDA, Md., May 3, 2007—The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions. (Fri, 04 May 2007 14:10:24 GMT)
New Report Examines Strategies for Exploiting the Power of Genomics to Inform Studies in Immunology
Research and Markets (http://www.researchandmarkets has announced the addition of Decoding the Genomic Control of Immune Reactions: Novartis Foundation Symposium, No 281 to their offering. (Fri, 04 May 2007 15:01:36 GMT)
Aptamer biosensors: an alternative to immunosensors
Research stemming from the Human Genome Project has increased the demand for and applications of DNA sensors. Several commercial platforms are now available, including those of Affymetrix (Santa Clara, CA) and Illumina (San Diego). (Fri, 04 May 2007 15:52:46 GMT)
TriMark Publications Announces Release of Its Clinical Laboratory Testing Reports
TriMark Publications (http://www.trimarkpublication a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Clinical Laboratory Testing reports Volumes 1 and 2. (PRWeb May 4, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.ph (Fri, 04 May 2007 16:09:54 GMT)
TriMark Publications Announces Release of Its Clinical Laboratory Testing Reports
TriMark Publications (http://www.trimarkpublication a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Clinical Laboratory Testing reports Volumes 1 and 2. (Fri, 04 May 2007 16:17:00 GMT)
Study To Probe How Healthy Younger Adults Make Use Of Genetic Tests
The National Human Genome Research Institute and the National Cancer Institute, parts of the National Institutes of Health, have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions. The study is called the Multiplex Initiative. (Fri, 04 May 2007 17:06:26 GMT)
Florida Atlantic University and Torrey Pines Institute for Molecular Studies Enter into Agreement for Cancer Research
Florida Atlantic University and Torrey Pines Institute for Molecular Studies (TPIMS) have signed an agreement to use compounds from TPIMS to enable faculty and students from the Charles E. Schmidt College of Science to work to identify anti-cancer drugs and therapies. (Fri, 04 May 2007 17:46:00 GMT)
Sleep Deprivation Can Threaten Competent Decision-Making, Judicial Sleepiness Regarded With High Level Of Negativity
Gambling is a risky activity that can potentially result in the loss of a significant amount of money. Sleep deprivation can adversely affect a person's decision-making at a gambling table by elevating the expectation of gains and making light of one's losses following risky decisions. [click link for full article] (Fri, 04 May 2007 19:06:46 GMT)
Ashley Bolden
entered the University of Missouri-Columbia (MIZZOU) planning a career as a medical doctor. But four years of undergraduate research—washing lab dishes her freshman year and working up to a nationally recognized project on the effects of estrogen on rats—opened her eyes to new possibilities. (Fri, 04 May 2007 19:29:35 GMT)
New virus test technology experimented
A new virus test technology featuring DNA test has entered the phase of clinical experiment, said a scientist in east China. (Sat, 05 May 2007 02:37:46 GMT)
Biotech Sector To Get Further Boost With Signing Of MOUs
BOSTON, May 5 (Bernama) -- Malaysia's biotechnology endeavour is set to get a further boost with the memorandums of understanding (MOUs) to be sealed at the BIO International Convention 2007 (BIO 2007) next week. (Sat, 05 May 2007 04:48:24 GMT)
Universities Can Help Speed Up Biotech Development In M'sia
BOSTON (US), May 5 (Bernama) -- Local universities can help speed up the biotechnology sector's development, especially through research and development activities related to the industry individually or on a joint venture basis, Science, Technology and Innovation Minister Datuk Seri Dr Jamaludin Jarjis said today. (Sat, 05 May 2007 05:48:24 GMT)
Rare 'Gene-For-Gene' Interaction That Helps Bacteria Kill Their Host, Discovered By Scientists
Scientists have discovered that a cousin of the plague bacterium uses a single gene to out-fox insect immune defences and kill its host.In research published in the journal Proceedings of the National Academy of Science, scientists have found that Photorhabdus bacteria produce an antibiotic which inhibits the work of an enzyme that insects' immune systems use to defend themselves from attack. ... (Sat, 05 May 2007 20:04:22 GMT)
Outlook: School's In
Education historically offers strong opportunities for architects, designers, and builders. New schools accommodate population growth and renovations repair and upgrade aging facilities. These needs haven't lessened. (Sun, 06 May 2007 01:17:17 GMT)
Scientists coming to region to join cancer fight
State-of-the art labs, monetary support and a large patient population make the area attractive. (Sun, 06 May 2007 04:10:19 GMT)
Pittsburgh key in fight against cancer
Men and women in Western Pennsylvania are fighting to save the half-million Americans who will die from cancer each year. (Sun, 06 May 2007 04:10:49 GMT)
Designer crops, better health — genetic changes aren't top priority
KANNAPOLIS — Not only will scientists at the N.C. Research Campus create designer diets, they will breed and grow designer crops intended to boost nutrition, improve taste and fight disease and famine. (Sun, 06 May 2007 06:10:11 GMT)
What is Biotechnology?
What is biotechnology? In a strict sense, it means altering live cells and putting them to work. By splicing new genes into the DNA of bacteria or other organisms, scientists can program them to make drugs. They can also introduce new genes into crops and create microbes that produce industrial chemicals. (Sun, 06 May 2007 07:08:53 GMT)
Echinacea And St John's Wort Research At Iowa State Renewed By $4.4 Million NIH Grant
A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years.The Iowa Center for Research on Botanical Dietary Supplements at Iowa State University was created in 2002 by the NIH Office of Dietary Supplements. ... (Sun, 06 May 2007 09:04:32 GMT)
All work and no play? Hardly
Many biotech giants have their headquarters in or around Cambridge's Kendall Square, just a short distance from the Massachusetts Institute of Technology. The square is still mostly a place to do business, but the high concentration of companies is also starting to spawn its own culture, with bars and lunch spots in the area catering to the biotech set. Here's ... (Sun, 06 May 2007 09:23:17 GMT)
The future of biotech: Experts look at what's next
THE BIOTECHNOLOGY GURU Robert S. Langer (Sun, 06 May 2007 09:23:37 GMT)
Springer Launches New Journal In Ophthalmology
Springer will launch a new multidisciplinary journal in ophthalmic research, the Journal of Ocular Biology, Diseases, and Informatics, in March 2008. The journal will be published under the Humana Press imprint. The publication will cover all aspects of research on ocular biology, including blinding diseases which affect more than 20 million people in the United States alone. [click link for full ... (Sun, 06 May 2007 11:04:22 GMT)
The trickle of good jobs has begun
Fred Zeigler is among the first. Give us more of him, and things will change. New technology will replace old industry. Jobs will come instead of leave. Company names like Medcotek and Pharmideas will roll off of our lips the way Trico and Bethlehem Steel once did. (Sun, 06 May 2007 11:26:08 GMT)
All work and no play? Hardly
Many biotech giants have their headquarters in or around Cambridge's Kendall Square, just a short distance from the Massachusetts Institute of Technology. The square is still mostly a place to do business, but the high concentration of companies is also starting to spawn its own culture, with bars and lunch spots in the area catering to the biotech set. Here's ... (Sun, 06 May 2007 14:37:55 GMT)
Novel antitumour agent
Small peptide that has shown encoraging anticancer activity in vitro and in vivo (Sun, 06 May 2007 18:05:46 GMT)
Wallaby Milk Compounds Effective Against Antibody Resistant "Superbugs"
Scientists from Victoria, Australia, have begun pre-clinical trials of a compound found in wallaby milk designed to fight antibiotic resistant 'superbugs.' "This is an important step towards the development of the antimicrobial compound AGG01 which may prove vital in the war against increasingly resistant human and animal diseases," announced Victorian Premier Steve Bracks at Bio 2007 in Boston. (Sun, 06 May 2007 18:25:00 GMT)
Wallaby Milk Compounds Effective Against Antibody Resistant "Superbugs"
Scientists from Victoria, Australia, have begun (Sun, 06 May 2007 21:02:34 GMT)
Wallaby Milk Compounds Effective Against Antibody Resistant "Superbugs"
Scientists fromVictoria, Australia, have begun pre-clinical trials of a compound found inwallaby milk designed to fight antibiotic resistant 'superbugs.' 'This isan important step towards the development of the antimicrobial compoundAGG01 which may prove vital in the war against increasingly resistant humanand animal diseases,' announced Victorian Premier Steve Bracks at Bio 2007in Boston. (Sun, 06 May 2007 22:16:59 GMT)
Single gene is responsible for most cool temperature sensation
The discovery, reported in the May 3 issue of the journal Neuron, might one day lead to the development of drugs that induce cold sensation as an analgesic, or block it to prevent certain forms of chronic pain associated with cold sensation. (Mon, 07 May 2007 02:05:12 GMT)
There may be a real code to chromosomal organization
The identification of a cluster of essential genes on mouse chromosome 11 as well as similar clusters on the chromosomes of other organisms , including humans , buttresses the argument that there may be rules as to how genes are structured or laid out on chromosomes, said the Baylor College of Medicine senior author of a report that appears online in the Public Library of Science Genetics, an ... (Mon, 07 May 2007 02:34:16 GMT)
Lab-on-a-chip speeds proteomics research
In recent years, the science of biology has been dominated by genomics, the study of genes and their functions. (Mon, 07 May 2007 02:49:27 GMT)
Renewal of Echinacea and St John's Wort research
A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years. (Mon, 07 May 2007 03:04:47 GMT)
Kiwi help in gene studies
Kiwi biologists will be able to use New Zealand-made software and high-speed grid computing to solve genetics puzzles starting in 2009. (Mon, 07 May 2007 03:15:49 GMT)
Genomes for the Masses
The proliferation and plummeting cost of DNA sequencing heralds the year of the personal genome. (Mon, 07 May 2007 04:07:13 GMT)
Leading Scientist And Innovator To Receive Honorary Degree
Craig Venter, an internationally known scientist who is responsible for developing high volume genome sequencing, will receive an honorary doctorate from Arizona State University on May 10 at a 9:30 a.m. commencement ceremony.An entrepreneur and maverick in both science and business, Venter was named Scientist of the Year by TIME magazine in 2000. [click link for full article] (Mon, 07 May 2007 06:04:11 GMT)
Starpharma's DNT Priostar(TM) Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents
Starpharma , through its US subsidiary company Dendritic Nanotechnologies Inc , has found that DNT's Priostar dendrimer technology can be used to amplify the signal and increase the duration of the signal of existing products in the multi-billion dollar fluorescent reagents market. (Mon, 07 May 2007 06:35:00 GMT)
Embracing biotechnology
THE REAL Massachusetts miracle is that we have thrived for nearly four centuries in a place that lacks almost every natural advantage except cranberries. We have achieved this by reinventing ourselves. (Mon, 07 May 2007 06:53:43 GMT)
Accept GM food, expert says
AUSTRALIANS will have to accept genetically modified (GM) food if the agriculture industry is to continue in an era of climate change, a plant genetics expert says. (Mon, 07 May 2007 07:11:00 GMT)
Fostering innovation in drug discovery
The two critical components of today's research-driven organizations are people and high tech laboratories. Most research facilities are organized around the premise that putting together great scientists and good technologies would do the trick -- and reap a rich pipeline of new drugs. (Mon, 07 May 2007 08:20:56 GMT)
Bay State digs deep, grows up since BIO 2000
When BIO last held its conference in Boston seven years ago, the human genome hadn't been fully sequenced, biotech stock prices were soaring, bioinformatics was brand-new, and global pharmaceutical competition hadn't heated up yet. (Mon, 07 May 2007 08:21:16 GMT)
Future doctors could monitor health through music of the patients' genes
There's musical gene expression (see: Hank Williams the first, second, and third) and musical Gene expression (see: Gene Simmons with his tongue out). And then there's the Musical Gene Expression project at Harvard Medical School, which envisions a future where doctors will be able to tune in to the internal music of their patients. (Mon, 07 May 2007 08:33:51 GMT)
Starpharma's DNT Priostar(TM) Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents
MELBOURNE, Australia, May 7 /PRNewswire-FirstC (Mon, 07 May 2007 09:05:08 GMT)
Takara Bio Grants Transgenomic License for LA-PCR Technology
Tokyo, Japan, May 7, 2007 - (JCN Newswire) - Takara Bio Inc. (TSE: 4974) today announced that it has granted Transgenomic, Inc. a worldwide non-exclusive license to make, use and sell LA-PCR related products. (Mon, 07 May 2007 10:07:24 GMT)
Cartesian Gridspeed of New Zealand Launches Revolutionary Genomics Sequencing Software in US Market
AUCKLAND, New Zealand----Cartesian Gridspeed, a New Zealand bioinformatics software developer, will officially launch its SLIM Search product to the US market at the BIO 2007 Convention today in Boston. (Mon, 07 May 2007 11:02:00 GMT)
Intransa Delivers Industry's First Scalable 10 GbE Enterprise IP SAN
SAN JOSE, Calif.----Intransa, the global leader of scalable, network-centric IP storage solutions, today introduced the Intransa StorStac PCU100, the storage industry's first scalable 10 GbE Enterprise IP SAN. (Mon, 07 May 2007 11:30:00 GMT)
Invitrogen and FAST Create Premiere Life Science Search Capability
CARLSBAD, Calif. & OSLO, Norway & NEEDHAM, Mass.----Fast Search & Transfer (FAST), a leading developer of search technologies and Invitrogen Corporation , an industry leading provider of products and services for disease research and drug discovery, today announced that Invitrogen has implemented FAST ESP to enhance the scientific search and navigation capabilities within their award winning ... (Mon, 07 May 2007 12:00:00 GMT)
Avesthagen gets Rs 225 mn share capital investment from NYLIM India fund
Avestha Gengraine Technologies Pvt. Ltd., India's leading systems biology innovation company, has announced an Rs 225 million investment in share capital by New York Life Investment Management India Fund (FVCI II), LLC (NYLIM India Fund) through equity shares for a minority stake. (Mon, 07 May 2007 12:19:13 GMT)
Intransa Delivers Industry's First Scalable 10 GbE Enterprise IP SAN
SAN JOSE, Calif., BUSINESS WIRE -- Intransa, the global leader of scalable, network-centric IP storage solutions, today introduced the Intransa StorStac PCU100, the storage industry's first scalable 10 GbE Enterprise IP SAN. The StorStac Storage System PCU100 (Performance Controller Unit 100) joins Intransa's StorStac System family and is specifically optimized for content rich server and ... (Mon, 07 May 2007 12:39:00 GMT)
1 2 3 4 5 Next